Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Cardiopulmonary Toxicity of Thoracic Radiotherapy
A clinical trial is evaluating the cardiopulmonary toxicity of thoracic radiotherapy in patients with esophageal cancer and non-small cell l…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Firmonertinib Combined With Chemotherapy as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutanted NSCLC [Phase 2]
A Phase 2 trial is evaluating neoadjuvant Firmonertinib combined with chemotherapy for resectable stage II-IIIb EGFR-mutant non-small cell l…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
A clinical trial update indicates recruitment for a study using long-read sequencing to characterize EGFR alterations in EGFR-positive non-s…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Biomarkers for Risk Stratification in Lung Cancer
Ongoing clinical trial update focusing on biomarkers for risk stratification in lung cancer, with recruitment for solitary pulmonary nodule …
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: An Open-label, Single-arm Clinical Study of Stapokibart Injection in Combination with Tislelizumab Injection in Patients with Non-Small Cell Lung Cancer [Phase 2]
An open-label, single-arm Phase 2 trial evaluating Stapokibart in combination with tislelizumab for non-small cell lung cancer, with status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC [Phase 2]
A Phase II clinical trial evaluating SHR-1826 injections in patients with non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients
Clinical trial status update indicates an ongoing first-line study of sintilimab combined with platinum-containing double-agent chemotherapy…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Multimodal Prehabilitation in Patients with Lung Cancer Undergoing Neoadjuvant Therapy [NA]
This clinical trial update describes a study evaluating multimodal prehabilitation for patients with non-small cell lung cancer undergoing n…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update comparing pembrolizumab given every 12 weeks versus every 3 weeks in patients with non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Study to Evaluate D-1553 in Subjects With Solid Tumors [Phase 1, Phase 2]
This clinical trial update shows an ongoing Phase 1/2 study of D-1553 in adults with solid tumors, including non-small cell lung cancer and …
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Neoadjuvant Therapy of SBRT Sequencial with Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) [Phase 3]
Phase 3 neoadjuvant trial evaluating SBRT sequential therapy with toripalimab and chemotherapy in resectable Stage II-III non-small cell lun…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study of CLN-081 for non-small cell lung cancer with EGFR exon 20 mutations, and the study is …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating online adaptive stereotactic radiotherapy to eliminate planning target volume margins in centrally located early…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas [Phase 2, Phase 3]
A phase 2/3 clinical trial conducted by the University of Sao Paulo is evaluating platelet aggregability in patients with non-small cell lun…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: The Lived Experiences of Persons With Early Stage Non-small Cell Lung Cancer and Their Significant Other(s) Following Surgery: a Rapid Ethnographic Approach
A completed study describing the lived experiences of individuals with early-stage non-small cell lung cancer after surgery and their signif…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Study to Investigate the Family History of Cancer in Patients With Non-small Cell Lung Cancer (FAHIC - Lung).
Clinical trial update for the FAHIC-Lung study investigating the family history of cancer in patients with non-small cell lung cancer. The s…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC [Phase 3]
A Phase 3 clinical trial evaluating AK104 in patients with unresectable locally advanced non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Multicenter Cancer Biospecimen Collection Study
A multicenter cancer biospecimen collection trial sponsored by Cofactor Genomics is currently recruiting, covering multiple cancer indicatio…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: A Study of JMT203 in Patients With Cancer Cachexia [Phase 1]
Phase 1 trial evaluating JMT203 in cancer cachexia, including colorectal cancer and non-small cell lung cancer (also mentioning pancreatic c…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and Novel Cancer Drugs
A clinical trial studying combinations of monoclonal antibodies with novel cancer drugs to overcome resistance to EGFR neutralization in non…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC [Phase 2]
Phase II clinical study evaluating Befotertinib in patients with EGFR non-classical mutant non-small cell lung cancer is underway. The trial…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases [Phase 2]
A Phase 2 clinical trial at Zhejiang Cancer Hospital evaluates cerebrospinal fluid cytology-guided intrathecal chemotherapy with chemo-holid…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Study of LP-184 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Lantern Pharma's LP-184 is being studied in a phase 1/2 trial for advanced and metastatic solid tumors, with indications including glioblast…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis [NA]
A ClinicalTrials.gov entry describes a study evaluating high-dose furmonertinib in combination with bevacizumab and pemetrexed for EGFR-muta…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT [Phase 2]
A Phase 2 clinical trial is evaluating whole-body HER3 quantification using radiolabeled patritumab deruxtecan (HER3-DXd) PET/CT in non-smal…